Association of Non-Invasive Markers of Liver Fibrosis with HCV Coinfection and Antiretroviral Therapy in Patients with HIV

Bravo, A. A., Sheth, S. G., Chopra, S. (2001). Liver biopsy. New Engl. J. Med., 344, 495–500.10.1056/NEJM200102153440706Search in Google Scholar

Hettmansperger, T. P., McKean, J. W. (2011). Robust Nonparametric Statistical Methods. 2nd ed., New York, Chapman-Hall. 554 pp.10.1201/b10451Search in Google Scholar

Kaspar, M. B., Sterling, R. K. (2017). Mechanisms of liver disease in patients infected with HIV. BMJ Open Gastro, 4, e000166.10.1136/bmjgast-2017-000166Search in Google Scholar

Kim H. N., Nance, R., Rompaey, S. V., Delaney, J. C., Crane, H. M., Cachay, E. R., Geng, E., Boswell, S. L., Rodriguez, B., Eron, J., Saag, M., Moore, R. D., Kitahata, M. M. (2016). Poorly controlled HIV infection: An independent risk factor for liver fibrosis. J. Acquir. Immune Defic. Syndr., 72 (4), 437–443.10.1097/QAI.0000000000000992Search in Google Scholar

Kloke, J. D., McKean, J. W. (2012). Rfit: Rank-based estimation for linear models rank-regression. The R. Journal, 4 (2), 57–64.10.32614/RJ-2012-014Search in Google Scholar

Konerman, M. A., Mehta, S. H., Sutcliffe, C. G., Vu, T., Higgins, Y., Torbenson, M. S., Moore, R. D., Thomas, D. L., Sulkowski, M. S. (2014). Fibrosis progression in human immunodeficiency virus/hepatitis C virus coinfected adults: Prospective analysis of 435 liver biopsy pairs. Hepatol. Baltim. Md., 59, 767–775.10.1002/hep.26741Search in Google Scholar

Larrousse, M., Laguno, M., Segarra, M., De Lazzari, E., Martinez, E., Luis Blanco, J. L., León, A., Deulofeu, R., Miquel, R., Milinkovic, A., Lonca, M., Miró, J. M., Biglia, A., Murillas, J., Gatell, J. M., Mallolas, J. (2007). Noninvasive diagnosis of hepatic fibrosis in HIV/HCV-coinfected patients. J. Acquir. Immune Defic. Syndr., 46, 304–311.10.1097/QAI.0b013e3181520502Search in Google Scholar

Neuman, M. G., Cohen, L. B., Nanaua R. M. (2016). Hyaluronic acid as a non-invasive biomarker of liver fibrosis. Clin. Biochem., 49, 302–315.10.1016/j.clinbiochem.2015.07.019Search in Google Scholar

Peters, L., Neuhaus, J., Mocroft, A., Soriano, V., Rockstroh, J., Dore, G., Puoti, M., Tedaldi, E., Clotet, B., Kupfer, B., Lundgren, J. D., Klein, M. B., for the INSIGHT SMART Study Group. (2011). Hyaluronic acid levels predict increased risk of non-AIDS death in hepatitis-coinfected persons interrupting antiretroviral therapy in the SMART Study. Antivir. Ther.16 (5), 667–675.10.3851/IMP1815Search in Google Scholar

Qurishi, N., Kreuzberg, C., Lüchters, G., Effenberger, W., Kupfer, B., Sauerbruch, T., Rockstroh, J. K., Spengler, U. (2003). Effect of anti-retroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection. Lancet, 362, 1708–1713.10.1016/S0140-6736(03)14844-1Search in Google Scholar

Schmid, P., Bregenzer, A., Huber, M., Rauch, A., Jochum, W., Müllhaupt, B., Vernazza, P., Opravil, M., Weber, R., Swiss HIV Cohort Study. (2015). Progression of liver fibrosis in HIV/HCV co-infection: A comparison between non-invasive assessment methods and liver biopsy. PLoS ONE, 10 (9), e0138838.10.1371/journal.pone.0138838458785926418061Search in Google Scholar

Sterling, R. K., Lissen, E., Clumeck, N., Sola, R., Cassia, M., Correa, M.C., Montaner, J., Sulkowski, M. S., Torriani, F. J., Dieterich, D. T., Thomas, D. L., Messinger, D., Nelson, M. for the APRICOT Clinical Investigators. (2006). Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatol. Baltim. Md, 43, 1317–1325.10.1002/hep.2117816729309Search in Google Scholar